The sell-out UK Manufacturing Medicines Industry Partnership (MMIP) Annual Conference is taking place at Discovery Park today.
Sandwich, Kent, June 20 2019 - The sell-out UK Manufacturing Medicines Industry Partnership (MMIP) Annual Conference is taking place at Discovery Park today. Hosted by Discovery Park and Pfizer UK, Medicines Manufacturing Excellence in the UK is focused on securing the future of the industry via activities such as digital transformation and skills development. With plans to become a centre of excellence in advanced manufacturing, these are issues of strategic importance for the Park.
This plan is underlined by today’s announcement from Pfizer UK on a £5m investment in advanced paediatric manufacturing - the latest in its series of manufacturing and innovation investments on site, totalling £36m since 2018. In addition, Concept Life Sciences, another tenant, launched its state-of-the-art facility for the manufacture of active pharmaceutical ingredients for industry partners earlier this week.
At the conference, over 170 delegates will hear from the Association of the British Pharmaceutical Industry (ABPI), the BioIndustry Association (BIA), Eisai, GSK, Innovate UK, the Laboratory of the Government Chemist, Kate Barclay Consulting, Kent County Council, the Knowledge Transfer Network (KTN), the Medicines Manufacturing Innovation Centre, the Office for Life Sciences, Oxford Biomedica, Pfizer UK and Siemens. Topics to be covered include the impact of advanced digital technologies, developing the optimum skills and leadership base, advanced therapies and anchoring high value manufacturing activities in the UK in the future. The UK ABPI, BIA and KTN are partners in the conference and in MMIP.
Mayer Schreiber, CEO of Discovery Park, said, ‘Alongside Pfizer UK we’re delighted to be hosting the third MMIP Annual Conference here today. The issues being discussed are very pertinent to us as we build on this site’s manufacturing heritage to become a centre of excellence. As Discovery Park develops we expect many other companies to locate here to access the developing expertise and skills base, which will be boosted by the exciting new paediatric manufacturing activities announced by Pfizer today.
The news that Kent County Council is investing in a VC fund to support life sciences businesses at Discovery Park is another exciting development. It is a significant boost to our plans to build a world class and world-leading science park here.’
-ENDS-
For further information and media opportunities, please contact Emily Marmara at Pillory Barn on 01622 524 087, or email: emily@pillorybarn.co.uk
Editor’s Notes
About discovery park (WWW.discovery-park.co.uk)
Discovery Park has grown to be a thriving part of the South East’s life science community in its six years as a multi-business science campus. The site offers high quality laboratory, office and manufacturing facilities, the space and support to expand, access to local finance, and a strong local scientific talent pool.
The growing tenant community includes Pfizer, which built the site’s reputation as a centre for drug discovery and discovered some of the most famous drugs in the world here. Other tenants include Algaecytes, Canterbury Christ Church University, Centauri Therapeutics, Concept Life Sciences, Genea Biomedx, Mylan and Salvensis. Discovery Park is home to 160+ companies employing 3,500 employees in total. With easy connections to London, Europe and the world Discovery Park is a great place to build and grow your biotech, medtech or pharma business. Discover more via our website: – www.discovery-park.co.uk email: info@discovery-park.co.uk or call: 01304 614060. You can also follow us on social media.
@Discovery Park_ Discovery Park – Sandwich, Kent
What is the MMIP?
The Medicines Manufacturing Industry Partnership (MMIP) represents the voice of medicines manufacturers in the UK - established jointly by Government and the biopharmaceutical industry in 2014. As a recognised Expert Group of the Life Sciences Council, the MMIP directly supports the implementation of the Life Sciences Industrial Strategy. As an expert group of the Life Sciences Council, MMIP is directly concerned with the implementation of the Life Sciences Industrial Strategy.
